92 results
8-K
EX-10.1
INVA
Innoviva Inc
25 Aug 23
Innoviva Appoints Stephen Basso as Chief Financial Officer
5:24pm
, continuing, and irreparable injury to the members of the Company Group for which monetary damages would not be an adequate remedy. Therefore, I hereby agree … or threatened breach of the terms of this Agreement without the necessity of proving irreparable harm or injury as a result of such breach or threatened breach
8-K
EX-99.1
INVA
Innoviva Inc
23 Aug 22
Other Events
4:08pm
the risk of contamination or injury from these materials. In the event of contamination or injury resulting from our use of hazardous materials, we could … candidates or products that we may develop;
injury to our reputation and significant negative media attention;
- 13 -
withdrawal of clinical trial
SC TO-T
EX-99
INVA
Innoviva Inc
25 Jul 22
Third party tender offer statement
8:34am
and acknowledges that any such violation or threatened violation may cause irreparable injury to the other Party, and that, in addition to any other remedies
8-K
EX-10.1
il8wd8nhag69vr5ciqt
12 Jun 20
Departure of Directors or Certain Officers
4:42pm
8-K
EX-10.1
2bi9aw4tan1o8400azh
4 Oct 18
Departure of Directors or Certain Officers
5:21pm
8-K
EX-10.2
qantsam2ohe imquawdy
4 Oct 18
Departure of Directors or Certain Officers
5:21pm
8-K
EX-10.1
na1sjsd9feia8urq64
8 Aug 18
Departure of Directors or Certain Officers
4:44pm
8-K
EX-10.1
v8qv1oud9
5 Jun 14
Theravance, Inc. and Theravance Biopharma, Inc. Announce
12:00am
8-K
EX-10.2
ttzvb3c mvqiskzidy5g
21 Apr 14
Theravance Closes Private Placement of $450 Million of 9% Non-Recourse Notes Supporting Strategic Separation Process
12:00am